SCHEMBL1593837

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL14960302	0.85	—	—
	SCHEMBL1596404	0.78	ALDH1A1 (0.48)	IDO1TDO2HSD17B2
	SCHEMBL27398439	0.59	HSD17B2 (0.47)	IDO1TDO2HSD17B2
	SCHEMBL8549963	0.58	SLC34A1 (0.39)	—
	SCHEMBL21230200	0.58	—	—
	SCHEMBL21230197	0.58	—	—
	SCHEMBL719872	0.58	PDE2A (0.42)	IDO1TDO2
	SCHEMBL3105161	0.58	PDE2A (0.45)	IDO1TDO2HSD17B2
	SCHEMBL723030	0.58	PDE2A (0.42)	IDO1TDO2
	SCHEMBL3099329	0.58	PDE2A (0.39)	IDO1TDO2HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.